NEW DelHI, Chikumi 22 (Xinhua) - Mugadziri wejekiseni wekuIndia Bharat Biotech's Covaxin yakaratidza 77.8 muzana yekubudirira muchikamu chechitatu chemiedzo, nhepfenyuro dzakawanda dzemuno dzakashuma neChipiri.
"Bharat Biotech's Covaxin inoshanda ne77.8 muzana mukudzivirira kubva kuCCIDID-19, maererano nedatha kubva muchikamu chechitatu chemiedzo yakaitwa kune 25,800 vatori vechikamu muIndia," mushumo wakadaro.
Chiyero chekushanda chakabuda neChipiri mushure mekunge komiti yenyanzvi dzeDrugs Controller of India (DCGI) (SEC) yasangana ndokukurukura mhedzisiro.
Kambani yemishonga yakanga yaendesa chikamu chechitatu cheyedzo data yejekiseni kuDCGI mukupera kwesvondo.
Mishumo yakati kambani iri kutarisirwa kuita musangano we "pre-submission" nevakuru veWorld Health Organisation neChitatu, kuti vakurukure gwara rekutumira kwekupedzisira kwe data nemagwaro.
India yakatanga vaccine yakawanda kurwisa COVID-19 muna Ndira 16 nekupa maviri akagadzirwa-mu-India ekudzivirira, anoti Covishield neCovaxin.
Serum Institute yeIndia (SII) iri kugadzira AstraZeneca-Oxford University's Covishield, uku Bharat Biotech yakabatana neIndia Council of Medical Research (ICMR) mukugadzira Covaxin.
Mushonga wekudzivirira weSputnik V wakagadzirwa neRussia wakaparurwawo munyika.Enditem
Nguva yekutumira: Jun-25-2021